1HSIC Stock Overview

Provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. More details

1HSIC fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	2/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 51.1% below our estimate of its fair value

Earnings are forecast to grow 12.6% per year

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Significant insider selling over the past 3 months

Large one-off items impacting financial results

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Henry Schein, Inc. Competitors

Amplifon

BIT:AMP

€3.9b

DiaSorin

BIT:DIA

€5.4b

Sinopharm Group

SEHK:1099

HK$56.0b

Shanghai Pharmaceuticals Holding

SHSE:601607

CN¥59.3b

Price History & Performance

Summary of share price highs, lows and changes for Henry Schein
Historical stock prices
Current Share Price	US$58.10
52 Week High	US$0
52 Week Low	US$0
Beta	0.87
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	15.28%
Change since IPO	-7.70%

Recent updates

Shareholder Returns

	1HSIC	IT Healthcare	IT Market
7D	n/a	3.1%	3.0%
1Y	n/a	17.0%	12.6%

Return vs Industry: Insufficient data to determine how 1HSIC performed against the Italian Healthcare industry.

Return vs Market: Insufficient data to determine how 1HSIC performed against the Italian Market.

Price Volatility

Is 1HSIC's price volatile compared to industry and market?
1HSIC volatility
1HSIC Average Weekly Movement	n/a
Healthcare Industry Average Movement	5.6%
Market Average Movement	5.3%
10% most volatile stocks in IT Market	8.7%
10% least volatile stocks in IT Market	3.4%

Stable Share Price: 1HSIC's share price has been volatile over the past 3 months compared to the Italian market.

Volatility Over Time: Insufficient data to determine 1HSIC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1932	25,000	Stan Bergman	www.henryschein.com

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins.

Henry Schein, Inc. Fundamentals Summary

How do Henry Schein's earnings and revenue compare to its market cap?
1HSIC fundamental statistics
Market cap	€7.07b
Earnings (TTM)	€359.58m
Revenue (TTM)	€11.19b

20.0x

P/E Ratio

0.6x

P/S Ratio

Is 1HSIC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1HSIC income statement (TTM)
Revenue	US$12.67b
Cost of Revenue	US$8.67b
Gross Profit	US$4.00b
Other Expenses	US$3.60b
Earnings	US$407.00m

Last Reported Earnings

Mar 29, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	3.32
Gross Margin	31.60%
Net Profit Margin	3.21%
Debt/Equity Ratio	61.3%

How did 1HSIC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/05 16:22
End of Day Share Price	2025/05/05 00:00
Earnings	2025/03/29
Annual Earnings	2024/12/28

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Henry Schein, Inc. is covered by 39 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jeffrey Johnson	Baird
Ishan Majumdar	Baptista Research
Lawrence Marsh	Barclays

Henry Schein BIT:1HSIC Stock Report